Martin B. Ulmschneider

king's college london

H指数:30

被引数:4,082

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In Silico Prediction and Validation of the Permeability of Small Molecules Across the Blood–Brain Barrier

小分子穿过血脑屏障的渗透性的计算机预测和验证

International Journal of Molecular Sciences

IF4.9

2026-01-310

OAAI

PGLa and Magainin 2 Can Porate Membranes via Transient Hourglass-Shaped Toroidal Pores

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2026-01-010

PRE

Enhancing Selective Brain Cancer Therapy: Integrating Nanomedicine and Molecular Dynamics to Target the Cancerous Lipid Composition

增强选择性脑癌治疗：整合纳米医学和分子动力学以靶向癌性脂质组成

Nano Select

IF3.5

2025-11-090

OAAI

Mechanistic Disruption of the TREM2-DAP12 Transmembrane Complex by Alzheimer's Disease Mutations: A Multiscale Simulation Study

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2025-11-010

PRE

Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease

使用2-HDP清除丙烯醛可保护糖尿病视网膜疾病大鼠模型中的神经血管完整性

Diabetologia

IF10.2

2025-08-150

The difference between MelP5 and melittin membrane poration

SCIENTIFIC REPORTS

IF3.9

2025-03-030

OAAI

Blocking the Dkk1-LRP6 interaction prevents acute amyloid-(3-driven cognitive impairment

CELLULAR SIGNALLING

IF3.7

2025-03-010

Permeability Benchmarking: Guidelines for Comparing in Silico, in Vitro, and in Vivo Measurements

渗透性基准: 比较计算机，体外和体内测量的指南

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2025-01-170

OAAI

Computational investigation of the effect of BODIPY labelling on peptide-membrane interaction

SCIENTIFIC REPORTS

IF3.9

2024-11-120

OAAI

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole

NATURE COMMUNICATIONS

IF15.7

2024-09-280

OAAI

Melittin can permeabilize membranes via large transient pores

蜂毒肽可以通过大的瞬时孔渗透膜

NATURE COMMUNICATIONS

IF15.7

2024-08-230

OAAI

Unraveling the Molecular Dance: Insights into TREM2/DAP12 Complex Formation in Alzheimer's Disease through Molecular Dynamics Simulations

ACS OMEGA

IF4.3

2024-06-211

OAAI

Rapid Peptide Cyclization Inspired by the Modular Logic of Nonribosomal Peptide Synthetases

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2024-06-061

OAAI

Therapeutic Peptides Are Preferentially Solubilized in Specific Microenvironments within PEG-PLGA Polymer Nanoparticles

治疗性肽优先溶解在peg-plga聚合物纳米颗粒内的特定微环境中

NANO LETTERS

IF9.1

2024-02-022

OAAI

Modeling Substrate Entry into the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-12-142

Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS

IF6.8

2023-11-080

A least-squares-fitting procedure for an efficient preclinical ranking of passive transport across the blood-brain barrier endothelium

最小二乘拟合程序，用于有效地对跨血脑屏障内皮的被动运输进行临床前排名

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

IF3.1

2023-08-124

OAAI

Integrated Design of a Membrane-Lytic Peptide-Based Intravenous Nanotherapeutic Suppresses Triple-Negative Breast Cancer

ADVANCED SCIENCE

IF14.1

2022-03-0410

OAAI

Atomistic Model of Solute Transport across the Blood-Brain Barrier

跨血脑屏障溶质转运的原子模型

ACS OMEGA

IF4.3

2021-12-299

OAAI

Understanding and modelling the interactions of peptides with membranes: from partitioning to self-assembly

CURRENT OPINION IN STRUCTURAL BIOLOGY

IF7

2020-04-0132

PREAI

Martin B. Ulmschneider

个人简介

教育背景

工作经历

荣誉奖项

研究方向